Discontinued — last reported Q3 '25
West Pharmaceutical Services Lease Liability Payments - 2021 remained flat by 0.0% to $1.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $1.20M to $1.50M. This is a positive signal — lower values indicate better performance for this metric.
Higher payments indicate significant near-term cash requirements for leased assets, while lower payments suggest reduced short-term liquidity pressure from lease commitments.
This metric quantifies the specific portion of total lease liabilities, encompassing both operating and finance leases,...
This is a standard liquidity disclosure across all public companies following ASC 842 or IFRS 16 accounting standards, allowing for direct comparison of short-term lease-related cash outflows.
lease_liability_payments_2021| Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|
| Value | $900.00K | $900.00K | $1.20M | $1.30M | $1.50M | $1.50M |
| QoQ Change | — | +0.0% | +33.3% | +8.3% | +15.4% | +0.0% |
| YoY Change | — | — | — | +44.4% | +66.7% | +25.0% |